A New Era in the Treatment of Chronic Kidney Disease

ProKidney is a late clinical-stage biotech company focused on the development of a pioneering cell therapy candidate that aims to transform the treatment landscape for Chronic Kidney Disease, with the potential to preserve kidney function and change patients' lives.

Our Mission

ProKidney is a pioneer in the treatment of Chronic Kidney Disease (CKD). While current treatments for CKD can slow the progression of kidney failure, there is no cure for CKD. At ProKidney we are at the forefront in the field of cellular therapy focused on delaying the progression to kidney failure and the need for dialysis.

Addressing Multiple Areas of High Unmet Need

Current standard of care merely slows down the expected eventual loss of kidney function

Renal Autologous Cell Therapy: REACT

Early clinical data suggest REACT
may stop the progression of CKD, and may promote meaningful improvement in kidney function

Lead Platform Programs for CKD Treatment

ProKidney and REACT aim to disrupt the CKD treatment landscape